Engineering Lipid-Based Nanoparticles of a Doxorubicin PSA-Cleavable Prodrug for Advanced Prostate Cancer

Activity: Talk or presentation types › Oral presentation

Period04 Jun 2018 → 05 Jun 2018
Held atUKICRS, Belfast, United Kingdom
Degree of RecognitionNational